Mechelen, Belgium, 27 May 2021, 22:01 CET, - Galapagos NV (Euronext & Nasdaq: GLPG) today announced that 15 abstracts, including scientific updates, and data providing further understanding on the
Charitable books have been donated to Lamphey school Children at Lamphey primary school have been treated to books which will help them empathise with others more. The set of ‘The Abilities in Me’ books highlight that everyone is different and address the encounters and difficulties that people with certain conditions may face. A spokesperson for the primary school said: we would like to say a big thank you to Mrs Carys Beynon for arranging this following her son’s diagnosis of Juvenile Idiopathic Arthritis (JIA), an autoimmune disease that affects children and teens. The donations were given by the Dean Bevsy Evans Charity who aim to help children in a variety of ways including advancing educational training programmes.
in clinical practice.
The study, with target enrollment of 1500 patients across Europe, will evaluate the effectiveness, safety, and patient-reported outcomes (PROs) in patients with moderate to severe active RA while receiving filgotinib in a real-world setting for up to two years. Mobile device technology will play a central role in collection of PROs, allowing data collection to begin within the first weeks of treatment. This may also prove to be an effective tool during the pandemic, while in-person clinic visits are harder to achieve.
FILOSOPHY will enable the gathering of comprehensive real-world data in a population that may not be fully represented in clinical trials, as randomized, placebo-controlled trials require strict patient inclusion criteria. These data will expand the evidence base to support the appropriate use of filgotinib in clinical practice.
Galapagos NV: Galapagos announces first patient enrolled in FILOSOPHY study to advance understanding of Jyseleca (filgotinib) effectiveness and safety in a real-world setting
-
Mechelen
that the first patient has been enrolled
i
. The goal with patients with in clinical practice.
The study, with target enrollment of 1500 patients across Europe, will evaluate the effectiveness, safety, and patient-reported outcomes (PROs) in patients with moderate to severe active RA while receiving filgotinib in a real-world setting for up to two years. Mobile device technology will play a central role in collection of PROs, allowing data collection to begin within the first weeks of treatment. This may also prove to be an effective tool during the pandemic, while in-person clinic visits are harder to achieve.
Much loved by all his family. Donations if wished to Cancer Research c/o A Slade & Son, 35 Dyer Street, Cirencester, GL7 2PP. 01285 656336.
Roland Rowly Joseph Mottram Beloved dad, grampy, father-in-law and friend to many who sadly passed away peacefully on Saturday, April 24, surrounded by his children.
Myrtle Elizabeth Nelmes Wife of the late Den Nelmes and mother to Andrea, Andrew and Mary. Much loved mother-in-law, nan and great nan. Forever in our hearts. Donations to National Rheumatoid Arthritis Society c/o A Slade & Son, Ridgeway House, 35 Dyer Street, Cirencester, GL7 2PP.
Gloria Robertson Beloved wife of the late Morton and mother of Mark and Alistair.